Revisiting Rose: strategies for reducing coronary heart disease.
Manuel
Douglas G
DG
Institute for Clinical Evaluative Sciences, G106-2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5. doug.manuel@ices.on.ca
Lim
Jenny
J
Tanuseputro
Peter
P
Anderson
Geoffrey M
GM
Alter
David A
DA
Laupacis
Andreas
A
Mustard
Cameron A
CA
D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D003327:Coronary Disease / Q000517:prevention & control*; D006291:Health Policy; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000517:prevention & control; D006973:Hypertension / Q000517:prevention & control; D008875:Middle Aged; D018570:Risk Assessment; D012307:Risk Factors
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors